“It’s important to decrease blood pressure medications ... With that change, these medications will likely be used long term.” Learn more about how to get GLP-1 medications like Zepbound ...

Austin Chiang, MD, MPH: One innovation that's happening in my specialty of gastroenterology is artificial intelligence. Ben ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. Health News // 1 day ago Anesthesiologists warn about proper use of ...

Increased risks were seen for conditions such as low blood pressure ... this study cannot say for sure that GLP-1 use was the cause of the change in risk of different health outcomes.

However, the conclusion that GLP-1 use in some way drives greater PAP (positive airway pressure) therapy initiation ... the potential upside of changes in market dynamics that are uncertain ...

Systemic medications, particularly selective beta blockers and calcium channel blockers, can significantly influence intraocular pressure (IOP) over time, according to study results published in ...

LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors ... with CagriSema's broader class of GLP-1 receptor agonist drugs.

Other adverse effects Increased risks were seen for conditions such as low blood pressure ... study cannot say for sure that GLP-1 use was the cause of the change in risk of different health ...

2024 was a pivotal year for the patient support landscape, as the space underwent a substantial shift shaped by market dynamics, regulatory changes, and the evolving ... 5.The impact of GLP-1 ...

Six patients (1 ... use of contact lenses unless directed by an eye care professional. Refer patients to an eye care professional for an ophthalmic exam including visual acuity testing, slit lamp ...

The analysis included 98,147 GLP-1 RA users and approximately 2.49 million DPP-4i users, with a median follow-up ranging from 1.8 to 3 years. HealthDay News — Glucagon-like peptide 1 receptor ...